510(k) K260281
K260281 is an FDA 510(k) premarket notification submitted by BIOMERIEUX for the device "VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)". The FDA issued a decision of Substantially Equivalent on Mar 26, 2026. The device falls under product code LON (System, Test, Automated, Antimicrobial Susceptibility, Short Incubation), a Class II device regulated under 21 CFR 866.1645. BIOMERIEUX has 272 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 26, 2026
- Date Received
- Jan 29, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
- Device Class
- Class II
- Regulation Number
- 866.1645
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for BIOMERIEUX? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.